dual SPINK1/EGFR inhibitors (University of Michigan)

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug Namedual SPINK1/EGFR inhibitors (University of Michigan)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKazal type serine peptidase inhibitors inhibitorsEpidermal growth factor receptor erbB1 inhibitors
TargetsKazal type serine peptidase inhibitorsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Michigan
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A